Amitava Mitra
Impact in
- Pharmaceutical Science top 0.5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Drug Solubulity and Delivery Systems 25
- Advanced Drug Delivery Systems 7
-
- Pharmacogenetics and Drug Metabolism 5
- Co-authors
- Filippos KesisoglouHamidreza GhandehariBruce R. LineAnjan NanYunhui WuSenshang LinHala M. FaddaWei Zhu
- Journals
- Molecular Pharmaceutics (8 papers)The AAPS Journal (7 papers)Journal of Pharmaceutical Sciences (6 papers)Clinical Pharmacology & Therapeutics (4 papers)European Journal of Pharmaceutics and Biopharmaceutics (3 papers)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
Amitava Mitra
50 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 121
- Pharmaceutical Science 744
- Biomaterials 346
- Analytical Chemistry 162
- Immunology and Allergy 83
- Statistics and Probability 106
Countries citing papers authored by Amitava Mitra
This map shows the geographic impact of Amitava Mitra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amitava Mitra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amitava Mitra more than expected).
Fields of papers citing papers by Amitava Mitra
This network shows the impact of papers produced by Amitava Mitra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amitava Mitra. The network helps show where Amitava Mitra may publish in the future.
Co-authors
The 25 scholars most cited alongside Amitava Mitra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2024 | 24 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 6 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 6 | |
| 8 | 2022 | 7 | |
| 9 | 2020 | 41 | |
| 10 | 2020 | 12 | |
| 11 | 2020 | 17 | |
| 12 | 2019 | 37 | |
| 13 | 2019 | 78 | |
| 14 | 2018 | 20 | |
| 15 | 2017 | 63 | |
| 16 | 2016 | 10 | |
| 17 | 2015 | 41 | |
| 18 | 2014 | 53 | |
| 19 | 2006 | 59 | |
| 20 | 2004 | 46 |
About Amitava Mitra
Amitava Mitra is a scholar working on Pharmaceutical Science, Pharmacology, Analytical Chemistry, Statistics and Probability and Dermatology, having authored 52 papers that have together received 1.7k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (25 papers), Protein purification and stability (10 papers), Crystallization and Solubility Studies (8 papers), Advanced Drug Delivery Systems (7 papers), Pharmaceutical studies and practices (7 papers), Analytical Methods in Pharmaceuticals (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Statistical Methods in Clinical Trials (5 papers). The work is most often cited by research in Pharmaceutical Science (744 citations), Biomaterials (346 citations), Analytical Chemistry (162 citations), Immunology and Allergy (83 citations) and Statistics and Probability (106 citations). Amitava Mitra has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Filippos Kesisoglou, Hamidreza Ghandehari, Bruce R. Line, Anjan Nan, Yunhui Wu, Senshang Lin, Hala M. Fadda, Wei Zhu, Peter Dogterom and Sandra Suarez‐Sharp. Their work appears in journals such as Molecular Pharmaceutics, The AAPS Journal, Journal of Pharmaceutical Sciences, Clinical Pharmacology & Therapeutics and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.